PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
Aim. To study what cardiac drugs currently have any comments on biomarkers and what information can be obtained by pharmacogenetic testing using data exome sequencing in patients with cardiac diseases.Material and methods. Exome sequencing in random participant of the ATEROGEN IVANOVO study and bioi...
Saved in:
| Main Authors: | N. V. Shcherbakova, A. I. Ershova, A. A. Suvorova, E. Y. Hlebus, A. N. Meshkov, S. A. Boytsov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/303 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXOME SEQUENCING AND THE DIAGNOSTICS OF COMPLEX DISEASE PREDISPOSITION IN PREVENTIVE MEDICINE
by: N. V. Shcherbakova, et al.
Published: (2013-12-01) -
DIFFERENTIAL DIAGNOSIS OF HEREDITARY SYNDROME OF HYPOCHOLESTEROLEMIA BY USING EXOMIC SEQUENCING
by: A. I. Yershova, et al.
Published: (2015-09-01) -
Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-05-01) -
Correction: Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-07-01) -
Pharmacogenomics-Based Detection of Variants Involved in Pain, Anti-inflammatory and Immunomodulating Agents Pathways by Whole Exome Sequencing and Deep in Silico Investigations Revealed Novel Chemical Carcinogenesis and Cancer Risks
by: Alireza Sharafshah, et al.
Published: (2025-02-01)